Toll Free: 1-888-928-9744
Published: May, 2016 | Pages:
134 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
The Europe Human Coagulation Factor VIII Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the human coagulation factor VIII industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The human coagulation factor VIII market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The human coagulation factor VIII industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 194 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents 1 Industry Overview 1 1.1 Definition and Specifications of Human Coagulation Factor VIII 1 1.1.1 Definition of Human Coagulation Factor VIII 1 1.1.2 Specifications of Human Coagulation Factor VIII 2 1.2 Classification of Human Coagulation Factor VIII 3 1.2.1 Recombinant Factor VIII 3 1.2.2 Plasma-derived Factor VIII 4 1.3 Applications of Human Coagulation Factor VIII 5 1.3.1 Hemophilia A 6 1.3.2 Spontanous + Traum 6 1.3.3 Surgical 7 1.4 Industry Chain Structure of Human Coagulation Factor VIII 7 1.5 Industry Overview of Human Coagulation Factor VIII 8 1.6 Industry Policy Analysis of Human Coagulation Factor VIII 9 1.7 Industry News Analysis of Human Coagulation Factor VIII 9 2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII 11 2.1 Bill of Materials (BOM) of Human Coagulation Factor VIII 11 2.1.1 Global Plasma Volume Analysis 12 2.1.2 Numbers of Plasma Collection Stations Analysis 14 2.1.3 Price Comparison of United States Cell Culture Media 15 2.2 Equipment Suppliers Analysis of Human Coagulation Factor VIII 15 2.3 Labor Cost Analysis of Human Coagulation Factor VIII 18 2.4 Other Costs Analysis of Human Coagulation Factor VIII 19 2.5 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII 20 2.6 Manufacturing Process Analysis of Human Coagulation Factor VIII 20 3 Technical Data and Manufacturing Plants Analysis 22 3.1 Commercial Production Date of Europe Key Manufacturers in 2015 22 3.2 Manufacturing Plants Distribution of Europe Key Human Coagulation Factor VIII Manufacturers in 2015 22 3.3 R&D Status and Technology Source of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 23 4 Production Analysis of Human Coagulation Factor VIII by Regions, Product Types, and Applications 24 4.1 Europe Production of Human Coagulation Factor VIII by Regions (Key State) 2011-2016 24 4.2 Europe Production of Human Coagulation Factor VIII by Product Types 2011-2016 28 4.3 Europe Sales of Human Coagulation Factor VIII by Applications 2011-2016 31 4.4 Price Analysis of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 35 4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Human Coagulation Factor VIII 2011-2016 36 5 Consumption Volume and Consumption Value Analysis of Human Coagulation Factor VIII by Regions 37 5.1 Europe Consumption Volume of Human Coagulation Factor VIII by Regions 2011-2016 37 5.2 Europe Consumption Value of Human Coagulation Factor VIII by Regions 2011-2016 41 5.3 Europe Consumption Price Analysis of Human Coagulation Factor VIII by Regions 2011-2016 45 6 Analysis of Human Coagulation Factor VIII Production, Supply, Sales and Market Status 2011-2016 46 6.1 Capacity, Production, Sales, and Revenue of Human Coagulation Factor VIII 2011-2016 46 6.2 Production Market Share and Sales Market Share of Human Coagulation Factor VIII 2011-2016 51 6.3 Sales Overview of Human Coagulation Factor VIII 2011-2016 57 6.4 Supply, Consumption and Gap of Human Coagulation Factor VIII 2011-2016 59 6.5 Import, Export and Consumption of Human Coagulation Factor VIII 2011-2016 59 6.6 Cost, Price, Revenue and Gross Margin of Human Coagulation Factor VIII 2011-2016 59 7 Analysis of Human Coagulation Factor VIII Industry Key Manufacturers 62 7.1 Baxter 62 7.1.1 Company Profile 62 7.1.2 Product Picture and Specifications 63 7.1.2.1 ADVATE (Recombinant coagulation factor VIII) 63 7.1.2.2 Recombinant 63 7.1.3 Capacity, Production, Price, Cost, Gross and Revenue 64 7.2 Bayer 65 7.2.1 Company Profile 65 7.2.2 Product Picture 66 7.2.2.1 Kogenate® FS, antihemophilic factor (recombinant) 66 7.2.3 Capacity, Production, Price, Cost, Gross and Revenue 67 7.3 Pfizer 68 7.3.1 Company Profile 68 7.3.2 Product Picture 70 7.3.2.1 XYNTHA® (antihemophilic factor (recombinant)) 70 7.3.2.2 REFACTO® (antihemophilic factor (recombinant)) 71 7.3.3 Capacity, Production, Price, Cost, Gross and Revenue 71 7.4 CSL 73 7.4.1 Company Profile 73 7.4.2 Product Picture and Specifications 74 7.4.2.1 Helixate FS (Recombinant coagulation factor VIII) 74 7.4.2.2 Helixate® NexGen 75 7.4.2.3 Humate-P® 75 7.4.2.4 Biostate® 76 7.4.2.5 Beriate? (Human coagulation factor VIII) 76 7.4.2.6 Monoclate-P® 77 7.4.3 Capacity, Production, Price, Cost, Gross and Revenue 77 7.5 Grifols 79 7.5.1 Company Profile 79 7.5.2 Product Picture and Specification 80 7.5.2.1 Fanhdi® 80 7.5.3 Capacity, Production, Price, Cost, Gross and Revenue 80 7.6 Octapharma 82 7.6.1 Company Profile 82 7.6.2 Product Picture and Specifications 83 7.6.2.1 nuwiq®( human coagulation factor VIII recombinant DNA) 83 7.6.2.2 octanate® 84 7.6.2.3 wilate® 84 7.6.3 Capacity, Production, Price, Cost, Gross and Revenue 85 7.7 BPL 87 7.7.1 Company Profile 87 7.7.2 Product Picture 88 7.7.2.1 Optivate 88 7.7.3 Capacity, Production, Price, Cost, Gross and Revenue 89 7.8 Kedrion 90 7.8.1 Company Profile 90 7.8.2 Product Picture 91 7.8.2.1 Human Coagulation Factor VIII (10ml) 91 7.8.2.2 Human Coagulation Factor VIII (5ml) 92 7.8.3 Capacity, Production, Price, Cost, Gross and Revenue 92 8 Price and Gross Margin Analysis 94 8.1 Analysis of Price 94 8.2 Gross Margin Analysis 94 8.3 Price Comparison by Regions 95 8.4 Price Analysis of Different Human Coagulation Factor VIII Product Types 95 8.5 Gross Margin Analysis of Different Human Coagulation Factor VIII Applications 95 9 Marketing Trader or Distributor Analysis of Human Coagulation Factor VIII 97 9.1 Marketing Channels Status of Human Coagulation Factor VIII 97 9.2 Traders or Distributors of Human Coagulation Factor VIII with Contact Information 98 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Human Coagulation Factor VIII 99 9.4 Europe Import, Export and Trade Analysis of Human Coagulation Factor VIII 99 10 Development Trend of Human Coagulation Factor VIII Industry 2016-2021 100 10.1 Capacity and Production Overview of Human Coagulation Factor VIII 2016-2021 100 10.2 Production Market Share by Product Types of Human Coagulation Factor VIII 2016-2021 101 10.3 Sales and Sales Revenue Overview of Human Coagulation Factor VIII 2016-2021 102 10.4 Europe Sales of Human Coagulation Factor VIII by Applications 2016-2021 103 10.5 Import, Export and Consumption of Human Coagulation Factor VIII 2016-2021 104 10.6 Cost, Price, Revenue and Gross Margin of Human Coagulation Factor VIII 2016-2021 105 11 Industry Chain Suppliers of Human Coagulation Factor VIII with Contact Information 106 11.1 Major Raw Materials Suppliers of Human Coagulation Factor VIII with Contact Information 106 11.2 Manufacturing Equipment Suppliers of Human Coagulation Factor VIII with Contact Information 107 11.3 Major Players of Human Coagulation Factor VIII with Contact Information 110 11.4 Key Consumers of Human Coagulation Factor VIII with Contact Information 111 11.5 Supply Chain Relationship Analysis of Human Coagulation Factor VIII 112 12 New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113 12.1 New Project SWOT Analysis of Human Coagulation Factor VIII 113 12.2 New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113 13 Conclusion of the Europe Human Coagulation Factor VIII Industry Report 2015 115
List of Tables and Figures Figure Picture of Human Coagulation Factor VIII (Plasma-derived Factor VIII) 2 Table Specifications of Human Coagulation Factor VIII 2 Table Specification Comparison of Human Coagulation Factor VIII 3 Figure Europe Production Market Share of Human Coagulation Factor VIII by Type in 2015 3 Figure Recombinant Factor VIII Picture 4 Figure Plasma-derived Factor VIII Picture 4 Table Applications of Human Coagulation Factor VIII 5 Figure 2015 Europe Human Coagulation Factor VIII Major Applications Sales Share 5 Figure Typical Application in Hemophilia A 6 Figure Typical Application in Spontanous + Traum 6 Figure Typical Application in Surgical 7 Figure Industry Chain Structure of Human Coagulation Factor VIII 7 Table Europe Human Coagulation Factor VIII Major Manufacturers 8 Figure Europe Human Coagulation Factor VIII Major Regions Status in 2015 8 Table Industry Policy of Human Coagulation Factor VIII 9 Table Industry News List of Human Coagulation Factor VIII 9 Table Bill of Materials (BOM) of Human Coagulation Factor VIII 11 Table Global Plasma Volume by Region 2011-2016 (M Liter) 12 Table Global Plasma Market Share by Region 2011-2016 12 Figure Global Plasma Market Share by Region 2011 13 Figure Global Plasma Market Share by Region 2015 13 Table Global Major Manufacturers Plasma volume 2011-2016 (M Liter) 14 Table Numbers of Blood Collection Stations 2011-2016 14 Figure Price Comparison of Cell Culture Media 2011-2016 15 Table the key equipment of Human Coagulation Factor VIII 15 Figure Equipment Specification of Industrial Centrifuges 17 Figure Equipment Specification of Industrial Incubator 18 Figure European 2014 Estimated Hourly Labor Costs 18 Table 2015 Europe Electricity Price of Industry (USD/KWh) by Country 19 Table Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII in 2015 20 Figure Manufacturing Process Analysis of Recombinant Factor VIII 20 Figure Manufacturing Process Analysis of Plasma-derived Factor VIII 21 Table Commercial Production Date of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 22 Table Manufacturing Plants Distribution of Europe Key Human Coagulation Factor VIII Manufacturers in 2015 22 Table R&D Status and Technology Source of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 23 Table Europe Production of Human Coagulation Factor VIII by Regions 2011-2016 (K Bottles) 24 Table Europe Production Market Share of Human Coagulation Factor VIII by Regions 2011-2016 24 Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2011 25 Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2012 25 Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2013 26 Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2014 26 Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2015 27 Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2016 27 Table Europe Production of Human Coagulation Factor VIII by Product Types in 2011-2016 (K Bottles) 28 Table Europe Production Market Share of Human Coagulation Factor VIII by Product Types in 2011-2016 28 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2011 28 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2012 29 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2013 29 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2014 30 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2015 30 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2016 31 Table Europe Sales of Human Coagulation Factor VIII by Applications 2011-2016 (K Bottles) 31 Table Europe Sales Market Share of Human Coagulation Factor VIII by Applications 2011-2016 31 Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2011 32 Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2012 32 Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2013 33 Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2014 33 Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2015 34 Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2016 34 Figure Price Comparison of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 (USD/Bottle) 35 Table Europe Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Human Coagulation Factor VIII 2011-2016 36 Table Europe Consumption Volume of Human Coagulation Factor VIII by Regions 2011-2016 (K Bottles) 37 Table Europe Consumption Volume Market Share of Human Coagulation Factor VIII by Regions 2011-2016 37 Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2011 38 Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2012 38 Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2013 39 Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2014 39 Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2015 40 Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2016 40 Table Europe Consumption Value of Human Coagulation Factor VIII by Regions 2011-2016 (M USD) 41 Table Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions 2011-2016 41 Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2011 42 Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2012 42 Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2013 43 Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2014 43 Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2015 44 Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2016 44 Table Consumption Price of Human Coagulation Factor VIII by Regions 2011-2016 (USD/Bottle) 45 Table Europe and Major Manufacturers Capacity of Human Coagulation Factor VIII 2011-2016 (K Bottles) 46 Table Europe Capacity Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 46 Table Europe and Major Manufacturers Production of Human Coagulation Factor VIII 2011-2016 (K Bottles) 47 Table Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 47 Table Europe and Major Manufacturers Sales of Human Coagulation Factor VIII 2011-2016 (K Bottles) 47 Table Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 48 Table Europe and Major Manufacturers Sales Revenue of Human Coagulation Factor VIII 2011-2016 (M USD) 48 Table Europe Sales Revenue Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 49 Figure Europe Capacity (K Bottles), Production (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2011-2016 49 Figure Europe Capacity Utilization Rate of Human Coagulation Factor VIII 2011-2016 50 Figure Europe Sales Revenue (M USD) and Growth Rate of Human Coagulation Factor VIII 2011-2016 50 Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2011 51 Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2012 51 Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2013 52 Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2014 52 Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2015 53 Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2016 53 Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2011 54 Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2012 54 Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2013 55 Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2014 55 Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2015 56 Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2016 56 Figure Europe Sales (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2011-2016 57 Table Europe and Major Manufacturers Local Sales of Human Coagulation Factor VIII 2011-2016 (K Bottles) 58 Table Europe and Major Manufacturers Export of Human Coagulation Factor VIII 2011-2016 (K Bottles) 58 Table Europe Supply, Consumption and Gap of Human Coagulation Factor VIII 2011-2016 (K Bottles) 59 Table Europe Import, Export and Consumption of Human Coagulation Factor VIII 2011-2016 (K Bottles) 59 Table Price of Europe Human Coagulation Factor VIII Major Manufacturers 2011-2016 (USD/Bottle) 59 Table Gross Margin of Europe Human Coagulation Factor VIII Major Manufacturers 2011-2016 60 Table Europe and Major Manufacturers Revenue of Human Coagulation Factor VIII 2011-2016 (M USD) 60 Table Europe Production (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Revenue (M USD) and Gross Margin of Human Coagulation Factor VIII 2011-2016 61 Table Baxter Company Profile List 62 Figure ADVATE Product Picture of Baxter 63 Figure Recombinant Product Picture of Baxter 63 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Baxter 2011-2016 64 Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Baxter 2011-2016 64 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Baxter 2011-2016 65 Table Bayer Company Profile List 65 Figure Kogenate� FS, antihemophilic factor (recombinant) Product Picture of Bayer 66 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Bayer 2011-2016 67 Figure Human Coagulation Factor VIII Local Sales (K Bottles) and Growth Rate of Bayer 2011-2016 67 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Bayer 2011-2016 68 Table Pfizer Company Profile List 68 Figure XYNTHA� (antihemophilic factor (recombinant)) Product Picture of Pfizer 70 Figure REFACTO� (antihemophilic factor (recombinant)) Product Picture of Pfizer 71 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Pfizer 2011-2016 71 Figure Human Coagulation Factor VIII Local Sales (K Bottles) and Growth Rate of Pfizer 2011-2016 72 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Pfizer 2011-2016 72 Table CSL Company Profile List 73 Figure Helixate FS Product Picture of CSL 74 Figure Helixate� NexGen Product Picture of CSL 75 Figure Humate-P� Product Picture of CSL 75 Figure Biostate� Product Picture of CSL 76 Figure Beriate? Product Picture of CSL 76 Figure Monoclate-P� Product Picture of CSL 77 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of CSL 2011-2016 77 Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of CSL 2011-2016 78 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of CSL 2011-2016 78 Table Grifols Company Profile List 79 Figure Fanhdi� Product Picture of Grifols 80 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Grifols 2011-2016 80 Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Grifols 2011-2016 81 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Grifols 2011-2016 81 Table Octapharma Company Profile List 82 Figure nuwiq� Product Picture of Octapharma 83 Figure octanate� Product Picture of Octapharma 84 Figure wilate� Product Picture of Octapharma 84 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Octapharma 2011-2016 85 Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Octapharma 2011-2016 86 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Octapharma 2011-2016 86 Table BPL Company Profile List 87 Figure Optivate Product Picture of BPL 88 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of BPL 2011-2016 89 Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of BPL 2011-2016 89 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of BPL 2011-2016 90 Table Kedrion Company Profile List 90 Figure Human Coagulation Factor VIII (10ml) Product Picture of Kedrion 91 Figure Human Coagulation Factor VIII (5ml) Product Picture of Kedrion 92 Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Kedrion 2011-2016 92 Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Kedrion 2011-2016 93 Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Kedrion 2011-2016 93 Table Human Coagulation Factor VIII Price by Product Types 2011-2016 (USD/Bottle) 94 Table Human Coagulation Factor VIII Price by Companies 2011-2016 (USD/Bottle) 94 Table Human Coagulation Factor VIII Gross Margin by Companies 2011-2016 94 Table Price Comparison of Human Coagulation Factor VIII by Regions 2011-2016 (USD/Bottle) 95 Table Price of Different Human Coagulation Factor VIII Product Types (USD/Bottle) 95 Table Gross Margin of Different Human Coagulation Factor VIII Applications 95 Figure Marketing Channels Analysis of Human Coagulation Factor VIII 97 Table Traders or Distributors of Human Coagulation Factor VIII with Contact Information 98 Figure Ex-work Price, Channel Price and End Buyer Price of Human Coagulation Factor VIII (USD/Bottle) in 2015 99 Table Europe Import, Export, and Trade of Human Coagulation Factor VIII (K Bottles) 99 Figure Europe Capacity (K Bottles), Production (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2016-2021 100 Figure Europe Capacity Utilization Rate of Human Coagulation Factor VIII 2016-2021 101 Table Europe Human Coagulation Factor VIII Production by Product Types 2011-2016 (K Bottles) 101 Table Europe Human Coagulation Factor VIII Production Market Share by Product Types 2011-2016 101 Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2021 102 Figure Europe Sales (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2016-2021 102 Figure Europe Sales Revenue (Million USD) and Growth Rate of Human Coagulation Factor VIII 2016-2021 103 Figure Europe Sales of Human Coagulation Factor VIII by Applications 2016-2021 (K Bottles) 103 Table Europe Production Market Share of Human Coagulation Factor VIII by Applications 2016-2021 103 Figure Europe Production Market Share of Human Coagulation Factor VIII by Applications in 2021 104 Table Europe Production, Import, Export and Consumption of Human Coagulation Factor VIII 2016-2021 (K Bottles) 104 Table Europe Production (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Revenue (M USD) and Gross Margin of Human Coagulation Factor VIII 2016-2021 105 Table Major Raw Materials Suppliers of Human Coagulation Factor VIII with Contact Information 106 Table Manufacturing Equipment Suppliers of Human Coagulation Factor VIII with Contact Information 107 Table Major Players of Human Coagulation Factor VIII with Contact Information 110 Table Key Consumers of Human Coagulation Factor VIII with Contact Information 111 Figure Supply Chain Relationship Analysis of Human Coagulation Factor VIII 112 Table New Project SWOT Analysis of Human Coagulation Factor VIII 113 Table New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113 Author List 116
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.